Metronidazole and albendazole susceptibility of 11 clinical isolates of Giardia duodenalis from France.
J Antimicrob Chemother
; 46(5): 819-21, 2000 Nov.
Article
em En
| MEDLINE
| ID: mdl-11062206
ABSTRACT
The metronidazole and albendazole susceptibility of 11 clinical isolates of Giardia duodenalis from France was determined using a neonatal mouse model and compared with the outcome in patients after standard metronidazole therapy (0.75 g/day for 5 days). All isolates found to be clinically resistant to metronidazole (4/11) exhibited an ID50 > 120 mg/kg in the mouse model. This therefore appears to be a suitable animal model in which to explore drug failures in human giardiasis.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Albendazol
/
Giardia lamblia
/
Fezes
/
Metronidazol
/
Anti-Infecciosos
/
Antiprotozoários
Idioma:
En
Ano de publicação:
2000
Tipo de documento:
Article